CRISPR construct designed to result in activation of a target gene when combined with a source of nuclease-dead Cas9 fused to a transcriptional activator domain. Constitutively expresses two sgRNAs, both of which target sequence upstream of the transcription start sites of CG3902 and RpL26.
